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When an enoylreductase enzyme of a modular poly-
ketide synthase reduces a propionate extender unit
that has been newly added to the growing polyketide
chain, the resulting methyl branch may have either S
or R configuration. We have uncovered a correlation
between the presence or absence of a unique tyro-
sine residue in the ER active site and the chirality of
the methyl branch that is introduced. When this
position in the active site is occupied by a tyrosine
residue, the methyl branch has S configuration,
otherwise it has R configuration. In a model PKS
in vivo, a mutation (Tyr to Val) in an erythromycin
PKS-derived ER caused a switch in the methyl
branch configuration in the product from S to R. In
contrast, alteration (Val to Tyr) at this position in a ra-
pamycin-derived PKS ER was insufficient to achieve
a switch fromR toS, showing that additional residues
also participate in stereocontrol of enoylreduction.
INTRODUCTION
Complexor reducedpolyketides constitute oneof the largest and
most structurally diverse classes of natural product, including
numerous clinically valuable antibacterial, antifungal, antitumor,
and immunosuppressant compounds. They are produced,
most prolifically byStreptomyces andallied filamentous bacteria,
by stepwise construction of the polyketide chain on modular
polyketide synthases (PKSs), giant assembly line multienzymes
in which each successive set (or module) of fatty acid synthase-
related enzymes normally catalyzes the extension of the polyke-
tide chain byoneunit, the intermediates remaining tethered to the
multienzyme during assembly (Staunton and Weissman, 2001).
Many striking mechanistic and structural similarities have been
observed between bacterial modular PKSs andmammalian fatty
acid synthases, butPKSsgeneratemuchgreater structural diver-
sity in their products (Smith and Tsai, 2007). A given PKSmay re-
cruit one of a variety of starter units, activated as their CoAesters;
in addition, different extender units may be used in each module
(usually either acetateunits frommalonyl-CoAorpropionateunits
from (2S)-methylmalonyl-CoA). Furthermore, the normal reduc-
tive activities of a fatty acid synthase (ketoreductase [KR], dehy-
dratase [DH], and enoylreductase [ER] activities), which normallyChemistry & Biology 15, 1231–12accomplish together the full reduction of the initially formed b-
ketoacyl group on the nascent chain, may or may not be present
in each PKS module, leading to different oxidation states and
a large number of alternative chemical structures (Staunton and
Weissman, 2001; Smith and Tsai, 2007).
The PKS-catalyzed assembly process also generates stereo-
chemical diversity, because carbon-carbon double bonds may
have either cis or trans geometry, and because of the chirality
of centers bearing hydroxyl groups (where they are retained)
and branching methyl groups (the latter arising from use of pro-
pionate extender units). Understanding how PKSs exert control
over the configuration of these stereocenters is crucial in ratio-
nalizing longstanding observations, codified as Celmer’s rules
(Celmer, 1965), of position-specific homology between natural
macrocyclic polyketides, as well as for current attempts to
create novel polyketide products by manipulating PKS genes.
Key elements of the molecular basis of this stereocontrol have
already been established. For example, if methyl-bearing cen-
ters in the polyketide chain are found to have opposite configu-
rations, even though only the (2S)-isomer of methylmalonyl-CoA
is used as a substrate (Marsden et al., 1994; Wiesmann et al.,
1995), it is in some cases because, in certain modules, after
condensation catalyzed by the KS domain, epimerization of
the initially formed (2R)-methyl-3-ketoacyl thioester allows
access to the opposite configuration at the C-2 methyl branch
(Weissman et al., 1997).
The chirality of C-3 hydroxyl groups is dictated by the KR do-
main, and comparison of amino acid sequences of KR domains
where the stereochemical outcome is known, together with
homology modeling, has allowed the identification of specific
amino acid residues at the KR active site in modular PKSs that
appear to correlate with the stereochemical outcome (Caffrey,
2003; Reid et al., 2003; Baerga-Ortiz et al., 2006; O’Hare et al.,
2006). From these experiments, it is clear that small energetic
differences arising from precisely placed ‘‘gatekeeper’’ residues
at the KR active site lead to the presentation of a different face of
the polyketide substrate to an otherwise essentially identical
catalytic site. The presence of these sequence motifs allows
confident prediction of the configuration of the polyketide prod-
uct, a potentially valuable tool for synthetic chemists wishing to
confirm the configuration of a target natural product for which
the biosynthetic genes are known (Janssen et al., 2007; Udwary
et al., 2007; Bock et al., 2008). A more elaborate extension of
these rules for ketoreduction has recently been proposed
(Keatinge-Clay, 2007) based on X-ray crystal structures of two
PKS KR domains.40, November 24, 2008 ª2008 Elsevier Ltd All rights reserved 1231
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stereochemical outcome of enoylreduction by the ER domain,
or to account for it by features of the active site. We now report
an unexpectedly precise correlation between a unique amino
acid residue in an ER domain and the chirality of the methyl
branch produced when a propionate extender unit is fully re-
duced in a PKS module by the action of that ER. Furthermore,
homology modeling has revealed that the diagnostic residue is
in the active site, and specific mutagenesis has confirmed its im-
portance for stereocontrol. The correlation holds true not only
for antibiotic-producing PKS multienzymes, but also for similar
PKSs that control the production of long-chain methyl-branched
fatty acids forming the highly complex cell walls of Mycobacte-
rium tuberculosis and other disease-causing mycobacteria
(Gokhale et al., 2007).
RESULTS
As shown in Figure 1, the accepted mechanism of ER-catalyzed
reduction, deduced from studies on fatty acid synthases (Smith
and Tsai, 2007), involves 1,4-nucleophilic addition of a hydride
ion from the coenzyme NADPH to the unsaturated thioester
intermediate, followed by stereospecific protonation at the
a-carbon, which establishes the configuration of the methyl
branch. Our initial hypothesis was that all PKS ER domains
have essentially the same active site architecture, and act
upon trans-alkene substrates by the samemechanism. Opposite
configurational outcomes are dictated by relatively minor
changes in the presentation of the substrate to the active site
as a result of differences in a few critical amino acid residues,
leading to protonation from the opposite face of the double
bond. For the vast majority of ER domains, the geometry of the
substrate (an unsaturated PKS-bound intermediate that does
not accumulate) has not been established by experiment. How-
ever, where this has been done, for PikER4 (Castonguay et al.,
2007) and for erythromycin PKS ER4 (EryER4) (Kellenberger
et al., 2008), the geometry was confirmed as trans. We were
therefore encouraged to examine publicly available ER
sequences for residues that might be diagnostic of the stereo-
chemical outcome of a given ER domain.
Multiple Sequence Alignment of ER Domains Reveals
a Unique Amino Acid Residue Predictive of the
Stereochemical Outcome of Enoylreduction
Multiple sequence alignments were constructed for all available
type I ER domains, in which a propionate unit becomes fully
Figure 1. The Reaction Catalyzed by ER Domains
1,4-Nucleophilic addition of hydride ion, delivered from NADPH, to the unsat-
urated thioester is followed by stereospecific protonation, which establishes
the configuration of themethyl branch. Anti addition to the double bond is illus-
trated, as demonstrated for mammalian fatty acid synthase (Smith and Tsai,
2007), but instances of syn addition are also known (Smith and Tsai, 2007).1232 Chemistry & Biology 15, 1231–1240, November 24, 2008 ª200reduced and gives rise to a methyl branch of known configura-
tion in the final polyketide product. Scrutiny of these sequence
alignments (Figure 2; see Supplemental Data available online)
revealed that there is a single amino acid that shows excellent
correlation with the configuration of the polyketide product for
those cases where it is known. This residue lies about 90 resi-
dues N terminal of a well-conserved HAAAGGVGMA consensus
sequence identified as the site of NADPH cofactor binding (Amy
et al., 1989). In those ER domains producing a (2S)-methyl
branch, a tyrosine (Y) residue is systematically conserved at
this position, whereas in those ER domains producing a (2R)-
methyl branch, a valine (V) residue (or occasionally alanine or
phenylalanine) is found at this position (Figure 2). This position
corresponds precisely to Tyr52 in the closely homologous
Escherichia coli enzyme quinone oxidoreductase (QOR; PDB
ID 1QOR) (Thorn et al., 1995). For ease of reference, this position
in the PKS ER domains is labeled 520, and other residues within
the ER domain are numbered relative to it. Among the ER
sequences analyzed, those processing a propionate extender
unit all appear to follow this trend, the only exception (Supple-
mental Data) appearing to be an ER domain from the myxobac-
terial soraphen PKS (Bedorf et al., 1993), soraphen ER3, which
acts on an unusual methoxy-branched extender unit (Wenzel
et al., 2006). The product of this PKS has been confirmed by
X-ray crystallography to have S configuration at the relevant
position, but the ER domain has a leucine instead of a tyrosine
at residue 520 (Ligon et al., 2002).
Homology Models of PKS ER Domains Place Residue 520
at the Active Site
As previously reported (Maier et al., 2006), searches of publicly
available databases readily show that the ERdomains ofmodular
PKSs are members of the medium-chain NAD(P)H-dependent
dehydrogenase/reductase (MDR) family of enzymes, and that
they share most significant homology with the QOR subfamily
(Persson et al., 1994). Homology models of the ERs from
6-deoxyerythronolide B synthase (DEBS) module 4 (EryER4)
and rapamycin synthase (RAPS) module 13 (rapamycin PKS
ER13 [RapER13]) were constructed based on the MDR enzyme
E. coli QOR (PDB ID 1QOR) (Thorn et al., 1995) as template
(24% sequence identity), as described in the Experimental Pro-
cedures. Theoverall foldpredicted forbothEryER4andRapER13
was essentially identical, and served to reveal key conserved
features of their predicted active sites (Figure 3). The position of
the bound NADPH cofactor could also be modeled with confi-
dence. Both model structures suggest that residue 520 (Tyr in
EryER4; Val in RapER13) lies at the active site, adjacent to the
C40 of NADPH, from which the hydride ion is transferred during
reduction (Figure 3).
Site-Directed Mutagenesis of ER Domains
in a Triketide Synthase Multienzyme
The bimodular PKS DEBS1-TE (Corte´s et al., 1995), housed in
a suitable strain of Saccharopolyspora erythraea or of a related
actinomycete, is an established model system for the study of
modular polyketide synthesis. It was engineered by relocating
the chain-terminating thioesterase domain from DEBS3 to the
C terminus of the bimodular DEBS1 protein, and the products
of this synthase are triketide lactones. In previous work, it has8 Elsevier Ltd All rights reserved
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by the full ‘‘reductive loop’’ (Kellenberger et al., 2008) of KR, DH,
and ER domains from DEBS module 4, the resulting triketide
synthase, referred to here as TKS-ery4, produces the triketide
lactones 1a and 1b fully reduced at C-3 (the a and b forms result
from the incorporation of either propionate or acetate as starter
units, respectively) (Figure 4A). In contrast, replacement of the
module 2 KR domain of DEBS1-TE by the reductive loop (KR,
DH, and ER domains) of RAPS module 13 resulted in a triketide
synthase, TKS-rap13, which produced triketide lactones 2a
and 2b (Figure 4B) (Kellenberger et al., 2008).The compounds
1a and 1b differ from compounds 2a and 2b in the configuration
of the methyl substituent at the C-2 position, a difference that
arises presumably from the differing stereospecificity of the
EryER4 and the RapER13 domains (Kellenberger et al., 2008).
The products of TKS-ery4 have (2S) configuration consistent
Figure 2. Sequence Alignment of a Portion of Representative ER Domains from PKSs
The position of the unique tyrosine (Y520) residue correlated with (2S) configuration in the polyketide product is marked with black triangles. The position of
the NADPH binding site is marked with gray bars. Residue numbering is that of E. coli QOR (PDB ID 1QOR) (Thorn et al., 1995) on which the ER domains
were modeled.
Figure 3. Homology Models of ER Domains
(A and B)Models of (A) EryER4 and (B) RapER13 with bound cofactor NADPHwere constructed using E. coliQOR (PDB ID 1QOR) (Thorn et al., 1995) as template.
The characteristic tyrosine (EryER4) and valine (RapER13) residues are highlighted in yellow, and NADPH is shown in dark blue.Chemistry & Biology 15, 1231–1240, November 24, 2008 ª2008 Elsevier Ltd All rights reserved 1233
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have (2R) configuration consistent with having Val at position 520.
To analyze the role of residue 520 more precisely, site-directed
mutagenesis was carried out at this position within the ER
domains of TKS-ery4 (Y520V) and TKS-rap13 (V520Y) (Figure 4).
The mutant DEBS1-TE genes were cloned (see Experimental
Procedures) into the integrative plasmids pYH141 and
pYH137, under the control of the inducible actI-actIIorf4 pro-
moter (McDaniel et al., 1994), and introduced by conjugation
into Streptomyces coelicolor CH999 (McDaniel et al., 1994),
where they integrated into the genome. Cultures of the recombi-
nant strains produced low (1–2 mg/L), but readily detectable
levels of triketide lactones that were not produced by the plas-
mid-free control strain. In this host, the Y520V TKS-ery4 mutant
produced compounds 2a and 2b as judged by LC-MS analysis
(Supplemental Data) and not the compounds 1a and 1b pro-
duced by the strain housing the parent PKS, TKS-ery4. This
change represents a switch in the configuration of theC-2methyl
group. In contrast, the V520Y TKS-rap13 mutant produced the
same compounds 2a and 2b as the strain housing the parent
PKS, TKS-rap13 (Supplemental Data). Authentic synthetic
samples of the known compounds 1a, 1b, 2a, and 2b, used for
calibration of the LC-MS, were the kind gift of Dr. M.L. Heathcote
(Department of Chemistry, University of Cambridge).
These initial results prompted further investigation using as
the host strain S. erythraea BIOT1717-JC2, an erythromycin-
overproducing strain from which essentially all erythromycin
PKS genes had been deleted. The PKS genes encoding TKS-
ery4 and TKS-rap13, as well as the mutant genes encoding
Y520V TKS-ery4 and V520Y TKS-rap13, were each introduced
Figure 4. Recombinant Triketide Synthases
Based on DEBS1-TE
(A and B) Schematic representation of the DEBS1-
TE-based triketide synthase (Corte´s et al., 1995)
with (A) the reductive loop (Kellenberger et al.,
2008) of ery module 4, or (B) the reductive loop
(Kellenberger et al., 2008) of rap module 13. The
products of the parent enzyme are shown along-
side those of the variants mutated at residue 520.
into BIOT1717-JC2 under the control of
the erythromycin PKS promoter, on suit-
able integrative plasmids. Fermentation
of the resulting recombinant strains
gave significantly increased yields of tri-
ketide lactones, all of which were a forms
(propionate starter unit derived), consis-
tent with the fact that the BIOT1717 strain
had originally been optimized for erythro-
mycin A production, which requires ex-
clusively propionate starter units. In
agreement with the observations made
using S. coelicolor, LC-MS analysis of
broth extracts showed that the strain en-
coding TKS-ery4 produced chiefly 1a,
but in this strain it was accompanied by
small amounts of 2a, which would not
have been detectable in the lower-yield-
ing S. coelicolor strain (Figure 5A). The BIOT1717-JC2 strain
containing Y520V TKS-ery4 produced product 2a only, in
amounts similar to that of the strain carrying the parent TKS-
ery4 (Figure 5B). The strain encoding TKS-rap13, and the strain
encoding V520Y TKS-rap13, both produced 2a at nearly equal
levels, and with no detectable amount of the other isomer (Fig-
ures 5C and 5D). The products of strains carrying TKS-ery4
and Y520V TKS-ery4 were coinjected into the LC-MS and
confirmed to migrate as separate peaks.
Prediction of the Configuration of Methyl-Branched
Cell Wall Lipids in Mycobacteria
Within their complex cell walls, the pathogenic mycobacteria
contain multiply methyl-branched, saturated lipids of polyketide
or fatty acid origin. These cell wall lipids give rise to the waxy en-
velope that is characteristic ofmycobacteria, and are considered
to be a major determinant of mycobacterial pathogenicity, with
important roles in the host-immune response (Gokhale et al.,
2007). We were interested to compare the experimentally deter-
mined methyl-branch configuration of these lipids to the config-
uration predicted on the basis of the indicator residue that we
had identified in the ER domains of the very similar PKS enzymes
of antibiotic-producing actinomycetes. The dimycocerosate es-
ters (DIMs), for example, are mycobacterial cell wall lipids that
contribute to the permeability barrier of the cell envelope and
have been shown to promote virulence in pathogenic mycobac-
teria (Cox et al., 1999; Camacho et al., 2001). The DIMs consist of
twomultiply methyl-branched, saturated acyl chains, mycocero-
sic acids, attached in ester linkage to neighboring hydroxyl
groups in a phthiocerol moiety (Figure 6). Both mycocerosyl1234 Chemistry & Biology 15, 1231–1240, November 24, 2008 ª2008 Elsevier Ltd All rights reserved
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All of the methyl branches of the DIMs found either inMycobac-
terium ulcerans, the causative agent of the disease known as
Buruli ulcer (Hong et al., 2008), or in the closely relatedMycobac-
terium marinum, share the same configuration (Daffe´ et al.,
1984). However, all are opposite in configuration to the methyl
branches in the otherwise chemically identical DIMs found in tu-
berculosis-causingM. tuberculosis and inMycobacterium bovis
and Mycobacterium leprae (Figure 6) (Daffe´ and Lane´elle, 1988;
Daffe´, 1991).
A mycocerosic acid synthase (Mas) multienzyme has previ-
ously been identified in bothM. tuberculosisH37Rv andM. bovis
BCG, and shown to biosynthesize branched mycocerosic acids
by the iterative elongation of n-fatty acyl-CoA with methylma-
lonyl-CoA followed by full reduction (Rainwater and Kolattukudy,
1983, 1985; Mathur and Kolattukudy, 1992). Scrutiny of se-
quence comparisons between the M. tuberculosis H37Rv and
M. bovis BCG Mas proteins and their closest homologs inM. ul-
cerans Agy99 andM. leprae revealed that, inM. ulcerans, the ER
domainof theMasprotein contains aTyr520 residue, correspond-
ing to the all-Smethyl-branchedmycocerosate. In contrast, inM.
tuberculosis,M. bovis, andM. leprae, which share the same all-R
methyl-branch configuration in the mycocerosyl moieties of their
DIMs, the 520 residue of the Mas ER domain is phenylalanine
(Supplemental Data).
For onemycobacterial PKS, the chirality of the product has not
been determined with certainty. b-Mannosyl phosphomycoket-
Figure 5. LC-MS Chromatograms of Trike-
tide Lactones Produced from Engineered
Triketide Synthases
(A–D) LC-MS traces of fermentation extracts from
S. erythraea strains housing, respectively: (A)
TKS-ery4; (B) Y520V TKS-ery4; (C) TKS-rap13;
and (D) V520Y TKS-rap13.
ides (MPMs) are important mycobacterial
antigens produced in trace amounts by
several pathogenic strains, including M.
tuberculosis, M. bovis, and M. avium
(Trivedi et al., 2005). MPMs are presented
to T cells by CD1c of infected cells as part
of the immune response (Moody et al.,
2000; Matsunaga et al., 2004; Trivedi
et al., 2005). The saturated fatty acid
chains of MPMs exhibit an intriguing
methyl-branching pattern (Figure 7).
Originally thought to be of isoprenoid or-
igin, MPMs are now known to be synthe-
sized by the action of a specific PKS
(Moody et al., 2000; Matsunaga et al.,
2004), the product of pks12, the largest
open reading frame in the M. tuberculo-
sis genome. Pks12 is a bimodular PKS,
which has been proposed to synthesize
the fatty acyl chains of MPMs by elon-
gating a long-chain acyl-CoA
primer through five rounds each of alter-
nating propionate and acetate units, derived, respectively, from
methylmalonyl-CoA and malonyl-CoA (Figure 7) (Trivedi et al.,
2005; Chopra et al., 2008). The first module of Pks12 is respon-
sible for incorporating the methyl-branched units, and analysis
of the sequence of the ER domain housed in this module
showed that the 520 position is always occupied by Phe and
not Tyr (Supplemental Data). We therefore predict an R config-
uration for every methyl branch.
MPMs have not yet been isolated in amounts sufficient to de-
termine their configuration directly. Meanwhile, others have un-
dertaken the preparation of wholly synthetic MPMs containing
all-S methyl branches, under the assumption (contrary to our
present prediction) that this is the more likely configuration
(van Summeren et al., 2006; de Jong et al., 2007). It is reported
that the synthetic all-S MPM induces a T cell response
comparable to that induced by an authentic MPM sample
from M. tuberculosis (de Jong et al., 2007).
DISCUSSION
The factors governing stereocontrol during ER-catalyzed reduc-
tion on modular PKSs have been obscure. The MDR family of
enzymes, to which the ER domains of modular PKS belong, is
structurally heterogeneous, and crystallographic and mechanis-
tic studies on enzymes most closely related to the ER domains
have lagged behind work on, for example, the bacterial type II
enoyl-(acyl carrier protein) reductases that are the target forChemistry & Biology 15, 1231–1240, November 24, 2008 ª2008 Elsevier Ltd All rights reserved 1235
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(A) The Mas PKS catalyzes the biosynthesis of the mycocerosyl moieties of DIMS (Rainwater and Kolattukudy, 1985) by the iterative extension of n-fatty acyl
chains by four successive propionate units, with ER-catalyzed enoylreduction occurring in every cycle.
(B) Configuration of DIMs in M. tuberculosis and M. ulcerans.diazaborine antibiotics, the biocide triclosan, and one of the tar-
gets for the first-line antituberculosis drug isoniazid (Levy
et al., 1999). In the latter enzymes, conserved lysine and tyro-
sine residues have been highlighted as important for catalysis,
which are also important in the KR domains of PKS multien-
zymes (Reid et al., 2003). Meanwhile, stereocontrol on KR
domains has been shown to involve subtle alterations in active
site architecture that together determine the direction of
approach of the substrate to a highly conserved catalytic
apparatus (Baerga-Ortiz et al., 2006; O’Hare et al., 2006).
We expected to uncover similar mechanisms at work in ER
active sites, but nevertheless were surprised to make the ob-
servation that we report here, that a single amino acid residue
differs systematically between PKS ER domains, yielding op-
posite configurations. It has previously been suggested that
Tyr52 in E. coli QOR (and corresponding tyrosine residues in
the homologous mammalian z-crystallins) might be essential
for catalytic activity, acting, for example, to polarize the thio-
ester carbonyl (Rao et al., 1997). However, the fact that
many fully functional modular PKS ERs have valine at this
position makes this proposal untenable. Our homology models
suggest that another conserved tyrosine residue (Tyr1250 in
either EryER4 or RapER13; Tyr130 of E. coli QOR) is a more
plausible candidate for a catalytically essential residue, as pre-
viously proposed (Persson et al., 1994).1236 Chemistry & Biology 15, 1231–1240, November 24, 2008 ª200The results of specific mutations confirm that a tyrosine resi-
due at 520 is not essential for catalysis, and support a key role
of the residue at this position in determining the stereochemical
course of reduction. The replacement of this single residue in the
EryER4 active site appears to be sufficient to alter the stereo-
chemistry of enoylreduction (and without substantial diminution
in overall yield of polyketide product) toward that seen with
RapER13. In contrast to the switch of configuration previously
achieved with a purified PKS KR domain (Baerga-Ortiz et al.,
2006), the switch seen here occurs in the context of a PKS
multienzyme, which encourages the view that highly targeted
mutagenesis could become a useful tool in engineering PKSs
to produce configurationally altered polyketide natural products.
In the higher-yielding S. erythraea expression system, analysis
showed that even the unmutated EryER4 domain gave rise to
a small amount of triketide lactone 2a, which has the ‘‘switched’’
(2R) configuration. Stereocontrol here may be imperfect,
because the ER4 in its native context would be presented with a
tetraketide rather than a diketide substrate. Possibly, too, the
chain-terminating thioesterase (TE) domain, the natural heptake-
tide substrate of which has (2R) rather than (2S) configuration,
might catalyze faster release of the triketide that leads to 2a
product. Taken together, the results suggest (as for the KR
domains) that the stereochemical outcome reflects a delicate
energetic balance between alternative ways in which the8 Elsevier Ltd All rights reserved
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The enzyme Pks12 catalyzes the biosynthesis of the mycoketide moiety of MPMs by iterative elongation of an n-fatty acyl chain with alternating propionate and
acetate extender units (five cycles each) (Trivedi et al., 2005), with ER-catalyzed enoylreduction occurring in every cycle.tethered substrate is presented to a highly conserved catalytic
apparatus.
Site-directed mutagenesis (V520Y) of the RapER13 domain
gave an enzyme that showed no obvious impairment of catalytic
function, and the triketide lactone product of which retained the
same configuration as the unmutated enzyme. Resequencing of
the appropriate region of DNA in the recombinant strain con-
firmed that the desired mutation had indeed been introduced.
In addition, consistent results were obtained in each of the
host strains S. coelicolor and S. erythraea. Further work is
needed to establish the exact molecular basis for the resistance
to the anticipated switch in the configuration of the product.
These results suggest, however, that other residues at the active
site remain to be identified that participate in stereocontrol, and
they again highlight the finely balanced energetic differences
between the different outcomes.
We have also shown here that the correlation of residue 520
with the configuration of the methyl branches in fully reducing
modules holds for certain mycobacterial modular PKS systems,
such as Mas that synthesizes (multiply methyl-branched)
mycocerosic acids. The ER domains of Mas can also be con-
vincingly modeled on 1QOR as template. In contrast, other ER
enzymes implicated in mycobacterial lipid formation appear to
have a different fold. For example, a trans-acting ER, Rv2953,
has been recently identified as catalyzing reduction of a double
bond during biosynthesis of the phthiocerol moiety of DIM
(Sime´one et al., 2007). This gives rise to a methyl-branched ster-
eocenter, which again inM. ulcerans is opposite in configuration
to that in M. tuberculosis, M. bovis, and M. leprae (Daffe´, 1991)
(Figure 6). The active site residues participating in stereocontrol
in Rv2953, and its homologs in other mycobacterial species, re-
main to be identified. For the multienzyme Pks12, which governs
the production of MPMs in pathogenic strains of mycobacteria,
our prediction is at odds with a previous proposal that was
used to justify the synthesis of all-S rather than all-RMPM. How-
ever, given the potential importance of these lipids in modulating
the host response to infection, it would be of considerable inter-
est (pending the direct determination of the correct geometry of
natural MPMs) to synthesize and determine the biological prop-
erties of the all-R methyl-branched MPMs as well. Meanwhile,
identification of ER residue 520 as tyrosine (or not) allows a robustChemistry & Biology 15, 1231–12prediction of methyl branch stereochemistry for the products of
PKS multienzymes, the genes of which are uncovered through
focused or genome-scale sequencing efforts.
SIGNIFICANCE
Exquisite stereochemical control is a central feature of the
biosynthesis of polyketide antibiotics onmodular polyketide
synthases (PKSs). We have explored the molecular basis for
the contribution to this control provided by the enoylreduc-
tase (ER) domain in thosemoduleswhere abranchingmethyl
group is introduced. By determining whether or not a unique
tyrosine residue is present in the ER active site, the configu-
ration of the polyketide product at the methyl branch can be
confidently predicted. This further strengthens an emerging
paradigm, according to which stereocontrol arises through
the presentation of a different face of the substrate to an es-
sentially invariant catalytic apparatus in each of the domains
of a PKS. The finely balanced energetic difference between
these presentational modes is highlighted by our finding
that mutation of this key residue in an intact PKS system
can switch the configuration of the product. This both illus-
trates a potential mechanism for natural evolution of these
multienzymes, and encourages further experiments to alter
that specificity by active site engineering.
EXPERIMENTAL PROCEDURES
Homology Modeling
The sequences of erythromycin PKS ER4 (EryER4) and rapamycin PKS ER13
(RapER13) were comparedwith all protein sequences deposited in Swiss Prot,
using the Blast v2.2 program (Altschul et al., 1997). A PSI-BLAST search in
each case produced an alignment between the EryER4 and RapER13 domains
and homologous proteins. Homologous proteins with known structure were
identified using the FUGUE homology recognition server (Shi et al., 2001).
FUGUE searches for homologs in the structural profile library derived from
the structure-based alignments in the HOMSTRAD database (Mizuguchi
et al., 1998), and uses the environment-specific substitution tables to gener-
ate, automatically, the best alignments for the top hits. The homolog found
with highest percentage identity (24%) to both ER domains was E. coli QOR
(PDB ID 1QOR). The alignments produced by FUGUE for this highest-scoring
hit were formatted and analyzed as previously described (Baerga-Ortiz et al.,
2006). The models of EryER4 and RapER13 were constructed with MODELER40, November 24, 2008 ª2008 Elsevier Ltd All rights reserved 1237
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using loop-building programs, as previously described (Baerga-Ortiz et al.,
2006). Final energy and structure minimization were performed using the
SYBYL force field (Tripos, Inc., St. Louis, MO). The models were validated
by PROCHECK (Laskowski et al., 1993) and by visual inspection using 3D
graphics software.
Construction of Plasmids
Constructs for S. coelicolor CH999
For TKS-ery4, the plasmid pJLK41 (Kellenberger et al., 2008) was subjected to
site-directed mutagenesis using primers 1 and 2 (Supplemental Data) to
introduce the mutation Y520V, resulting in plasmid pJLK41mut. The NdeI/
XbaI fragment of this plasmid was cloned into vector pCJR133, digested
with the same enzymes, to yield plasmid pYH141.
For TKS-raps13, the NdeI/XbaI fragment of pJLK27 (Kellenberger et al.,
2008) was ligated to the vector pCJR133 (Rowe et al., 1998), digested with
the same enzymes, yielding plasmid pYH136. The mutation V520Y was intro-
duced by site-directed mutagenesis using primers 3 and 4 (Supplemental
Data), resulting in plasmid pYH137.
Constructs for S. erythraea BIOT1717-JC2
For TKS-ery4, the NdeI/XbaI fragment of pJLK41 was ligated into pFS1 di-
gested with the same enzymes, resulting in plasmid pDK18.0. The NdeI/XbaI
fragment of pJLK41mut was subcloned into pFS1 to yield pDK18.1.
For TKS-raps13, the NdeI/XbaI fragment of plasmid pJLK27 was inserted
into vector pFS1 (comprising the FVWB integrase, an attB integration site,
the DEBS native promoter, an origin of transfer for conjugation, and an apra-
mycin resistance gene), digested with the same enzymes, resulting in plasmid
pDK19.0. The variant TKS-raps13-V520Y was likewise subcloned into pFS1,
resulting in plasmid pDK19.1.
Site-Directed Mutagenesis
Site-directed mutagenesis was carried out using either the QuikChange II
XL Site-Directed Mutagenesis Kit (Stratagene), following the manufacturer’s
instructions, or by overlap-extension PCR (Ho et al., 1989), using the primers
mentioned above. The mutations were confirmed by sequencing (DNA
Sequencing Facility, Department of Biochemistry, University of Cambridge,
Cambridge, UK).
Manipulation and Handling of Bacterial Strains
E. coli was routinely grown in 2TY medium (1.6% tryptone, 1% yeast extract,
0.5% NaCl, containing 25 mg ml1 kanamycin, 50 mg ml1 apramycin, or
25 mg ml1 chloramphenicol, if appropriate) at 37C and transformed and
maintained by standard procedures. E. coli ET12567/pUZ8002 (Kieser et al.,
2000) was used for conjugation, and E. coli DH10B for general cloning
purposes.
The plasmids pYH137 and pYH141 were introduced into S. coelicolor by
conjugation (Kieser et al., 2000). The resulting strains were grown at 30C in
TSBY liquid medium (3% tryptone soy broth, 10.3% sucrose, 0.5% yeast
extract) for strain maintenance and isolation of genomic DNA and on tap water
mediumagar (0.5%glucose, 1%sucrose, 0.5% tryptone, 0.25%yeast extract,
2% agar, pH 7.1, tap water) for the analysis of triketide lactone production.
Plasmids pDK18.0, pDK18.1, pDK19.0, and pDK19.1 were introduced into
S. erythraea BIOT1717-JC2 by conjugation (Kieser et al., 2000). For strain
maintenance and isolation of genomic DNA, M79 medium (1% glucose, 1%
peptone, 0.2% yeast extract, 0.6% NaCl, 1% casein hydrolysate, pH 7.0,
tap water) or TSBmedium (Bacto BD Tryptic Soy Broth) was used. For analysis
of triketide lactone production, eryP medium (5% glucose, 3% soybean flour,
0.3% (NH4)SO4, 0.5% NaCl, 0.6% CaCO3, Antifoam A Concentrate [Sigma],
50 mg ml1 apramycin, pH 7.0) was used, at 30C.
Analysis of Triketide Lactones
To isolate triketide lactone from S. coelicolor CH999 strains, a tap water
medium agar plate was extracted after 7 days of growth with ethyl acetate
(1.6% formic acid). The solvent was removed in vacuo, and the residual oil
dissolved in 600 ml methanol for analysis by LC-MS.
For the isolation from S. erythraea BIOT1717-JC2, a 10 ml TSB medium
(50 mg ml1 apramycin, 25 mg ml1 nalidixic acid) was grown at 30C for
3 days. A 1 ml aliquot of this starter culture was used to inoculate 25 ml of1238 Chemistry & Biology 15, 1231–1240, November 24, 2008 ª200eryP medium (Rowe et al., 1998) (50 mg ml1 apramycin). After 10 days at
30C, triketide lactone was extracted with 25 ml ethyl acetate (containing
1.6% formic acid), the organic phasewas removed in vacuo, and the remaining
oil redissolved in 1 ml methanol before being subjected to LC-MS analysis.
LC-MS analysis was carried out on an Agilent 1200 HPLC system fitted with
a Phenomenex ODS column (2503 2.00 mm, 5 mm) and a Finnigan LTQ mass
spectrometer system. The mobile phase used was a linear gradient from 95%
water, 5% acetonitrile, 0.1% formic acid to 30%water, 70% acetonitrile, 0.1%
formic acid over 35 min.
SUPPLEMENTAL DATA
Supplemental Data include two figures and two tables and can be found
with this article online at http://www.chembiol.com/cgi/content/full/15/11/
1231/DC1/.
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